Grandview Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Sell |
4,319
-562
| -12% | -$26K | 0.06% | 134 |
|
|
2025
Q1 | $298K | Buy |
4,881
+19
| +0.4% | +$1.16K | 0.11% | 101 |
|
|
2024
Q4 | $275K | Buy |
+4,862
| New | +$275K | 0.1% | 103 |
|
|
2024
Q2 | – | Sell |
-5,687
| Closed | -$308K | – | 61 |
|
|
2024
Q1 | $308K | Sell |
5,687
-34
| -0.6% | -$1.84K | 0.14% | 88 |
|
|
2023
Q4 | $294K | Sell |
5,721
-1,975
| -26% | -$101K | 0.15% | 86 |
|
|
2023
Q3 | $447K | Buy |
+7,696
| New | +$447K | 0.26% | 70 |
|
|
2023
Q2 | – | Sell |
-8,156
| Closed | -$565K | – | 67 |
|
|
2023
Q1 | $565K | Sell |
8,156
-757
| -8% | -$52.4K | 0.33% | 64 |
|
|
2022
Q4 | $641K | Buy |
8,913
+2
| +0% | +$144 | 0.4% | 59 |
|
|
2022
Q3 | $633K | Sell |
8,911
-630
| -7% | -$44.8K | 0.4% | 60 |
|
|
2022
Q2 | $735K | Buy |
9,541
+344
| +4% | +$26.5K | 0.41% | 57 |
|
|
2022
Q1 | $672K | Sell |
9,197
-206
| -2% | -$15.1K | 0.28% | 67 |
|
|
2021
Q4 | $586K | Buy |
+9,403
| New | +$586K | 0.24% | 78 |
|
|
2021
Q3 | – | Sell |
-15,484
| Closed | -$1.04M | – | 70 |
|
|
2021
Q2 | $1.04M | Sell |
15,484
-7,641
| -33% | -$511K | 0.57% | 46 |
|
|
2021
Q1 | $1.46M | Sell |
23,125
-3,057
| -12% | -$193K | 0.78% | 36 |
|
|
2020
Q4 | $1.62M | Sell |
26,182
-613
| -2% | -$38K | 1.06% | 29 |
|
|
2020
Q3 | $1.62M | Sell |
26,795
-2,632
| -9% | -$159K | 1.31% | 21 |
|
|
2020
Q2 | $1.73M | Buy |
+29,427
| New | +$1.73M | 1.51% | 19 |
|